178
Views
56
CrossRef citations to date
0
Altmetric
Original Research

Global time trends in the incidence of esophageal squamous cell carcinoma

, , &
Pages 717-728 | Published online: 19 Jun 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Sung-Bae Kim, Eric Van Cutsem, Jaffer Ajani, Lin Shen, Gisoo Barnes, Ningning Ding, Aiyang Tao, Tianyu Xia, Lin Zhan & Ken Kato. (2023) Tislelizumab in advanced/metastatic esophageal squamous cell carcinoma: health-related quality of life in Asian patients. Current Medical Research and Opinion 0:0, pages 1-7.
Read now
Jason C. Allaire, Mark Balk, Soraya Azmi, Heather L. Handl, Keri Yang & Gisoo Barnes. (2021) Use of PD-1 and PD-L1 inhibitors after first-line therapy in esophageal cancer patients in the US. Current Medical Research and Opinion 37:8, pages 1403-1407.
Read now

Articles from other publishers (53)

Junjie Huang, Don Eliseo Lucero-PrisnoIIIIII, Lin Zhang, Wanghong Xu, Sunny H. Wong, Siew C. Ng & Martin C. S. Wong. (2023) Updated epidemiology of gastrointestinal cancers in East Asia. Nature Reviews Gastroenterology & Hepatology 20:5, pages 271-287.
Crossref
Clara Moreira, Ceu Figueiredo & Rui Manuel Ferreira. (2023) The Role of the Microbiota in Esophageal Cancer. Cancers 15:9, pages 2576.
Crossref
Alyyah Malick, Ali Soroush & Julian A. Abrams. 2023. Esophageal Disease and the Role of the Microbiome. Esophageal Disease and the Role of the Microbiome 91 114 .
Max W. Sung & Virginia R. Litle. 2017. Holland‐Frei Cancer Medicine. Holland‐Frei Cancer Medicine 1 20 .
Sima Ardalan Khales, Azadeh Aarabi, Mohammad Reza Abbaszadegan & Mohammad Mahdi Forghanifard. (2022) INPP5A/HLA-G1/IL-10/MMP-21 Axis in Progression of Esophageal Squamous Cell Carcinoma. Iranian Biomedical Journal 26:6, pages 440-453.
Crossref
Lin Shen, Ken Kato, Sung-Bae Kim, Jaffer A. Ajani, Kuaile Zhao, Zhiyong He, Xinmin Yu, Yongqian Shu, Qi Luo, Jufeng Wang, Zhendong Chen, Zuoxing Niu, Longzhen Zhang, Tienan Yi, Jong-Mu Sun, Jianhua Chen, Guohua Yu, Chen-Yuan Lin, Hiroki Hara, Qing Bi, Taroh Satoh, Roberto Pazo-Cid, Hendrick-Tobias Arkenau, Christophe Borg, Florian Lordick, Liyun Li, Ningning Ding, Aiyang Tao, Jingwen Shi & Eric Van Cutsem. (2022) Tislelizumab Versus Chemotherapy as Second-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma (RATIONALE-302): A Randomized Phase III Study. Journal of Clinical Oncology 40:26, pages 3065-3076.
Crossref
E. Van Cutsem, K. Kato, J. Ajani, L. Shen, T. Xia, N. Ding, L. Zhan, G. Barnes & S.-B. Kim. (2022) Tislelizumab versus chemotherapy as second-line treatment of advanced or metastatic esophageal squamous cell carcinoma (RATIONALE 302): impact on health-related quality of life. ESMO Open 7:4, pages 100517.
Crossref
Eun Jeong Gong, Chang Seok Bang, Kyoungwon Jung, Su Jin Kim, Jong Wook Kim, Seung In Seo, Uhmyung Lee, You Bin Maeng, Ye Ji Lee, Jae Ick Lee, Gwang Ho Baik & Jae Jun Lee. (2022) Deep-Learning for the Diagnosis of Esophageal Cancers and Precursor Lesions in Endoscopic Images: A Model Establishment and Nationwide Multicenter Performance Verification Study. Journal of Personalized Medicine 12:7, pages 1052.
Crossref
Ji Zhang, Rino Bellocco, Weimin Ye, Jan Johansson, Magnus Nilsson & Mats Lindblad. (2022) Effect of sex on survival after resection of oesophageal cancer: nationwide cohort study. BJS Open 6:3.
Crossref
Eiko Saito, Tomonori Yano, Megumi Hori, Daisuke Yoneoka, Tomohiro Matsuda, Yichi Chen & Kota Katanoda. (2022) Is young‐onset esophageal adenocarcinoma increasing in Japan? An analysis of population‐based cancer registries. Cancer Medicine 11:5, pages 1347-1356.
Crossref
Uttam Sharma, Tushar Singh Barwal, Akanksha Khandelwal, Manjit Kaur Rana, Amrit Pal Singh Rana, Karuna Singh & Aklank Jain. (2022) Circulating Long Non-Coding RNAs LINC00324 and LOC100507053 as Potential Liquid Biopsy Markers for Esophageal Squamous Cell Carcinoma: A Pilot Study. Frontiers in Oncology 12.
Crossref
Femmie Vegt, Jessie J. J. Gommers, Hans Groenewoud, Peter D. Siersema, André L. M. Verbeek, Yonne Peters & Mireille J. M. Broeders. (2021) Trends and projections in the incidence of oesophageal cancer in the Netherlands: An age‐period‐cohort analysis from 1989 to 2041. International Journal of Cancer 150:3, pages 420-430.
Crossref
Anna Gillman, Michelle Hayes, Greg Sheaf, Margaret Walshe, John V. Reynolds & Julie Regan. (2022) Exercise-based dysphagia rehabilitation for adults with oesophageal cancer: a systematic review. BMC Cancer 22:1.
Crossref
Shao-Hua Xie, Giola Santoni & Jesper Lagergren. (2021) Menopausal hormone therapy and risk of oesophageal adenocarcinoma in a population-based cohort study. British Journal of Cancer 126:1, pages 129-133.
Crossref
Nayoung Kim. 2022. Sex/Gender-Specific Medicine in the Gastrointestinal Diseases. Sex/Gender-Specific Medicine in the Gastrointestinal Diseases 69 92 .
Jingrong Huang, Li Zhao, Chengxian Gong, Yi Wang, Yinzong Qu, Chunyan Ji & Jianmei Yang. (2021) Shikonin Promotes Apoptosis and Attenuates Migration and Invasion of Human Esophageal Cancer Cells by Inhibiting Tumor Necrosis Factor Receptor-Associated Protein 1 Expression and AKT/mTOR Signaling Pathway. Evidence-Based Complementary and Alternative Medicine 2021, pages 1-12.
Crossref
Ye Gao, Lei Xin, Ya-Dong Feng, Bin Yao, Han Lin, Chang Sun, Wei An, Zhao-Shen Li, Rui-Hua Shi & Luo-Wei Wang. (2021) Feasibility and Accuracy of Artificial Intelligence–Assisted Sponge Cytology for Community-Based Esophageal Squamous Cell Carcinoma Screening in China. American Journal of Gastroenterology 116:11, pages 2207-2215.
Crossref
Shao-Ming Wang, Hormuzd A. Katki, Barry I. Graubard, Lisa L. Kahle, Anil Chaturvedi, Charles E. Matthews, Neal D. Freedman & Christian C. Abnet. (2021) Population Attributable Risks of Subtypes of Esophageal and Gastric Cancers in the United States. American Journal of Gastroenterology 116:9, pages 1844-1852.
Crossref
Paramita Khairan, Tomotaka Sobue, Ehab Salah Eshak, Ling Zha, Tetsuhisa Kitamura, Norie Sawada, Motoki Iwasaki, Manami Inoue, Taiki Yamaji, Taichi Shimazu, Hiroyasu Iso & Shoichiro Tsugane. (2021) Association of dietary intakes of vitamin B12, vitamin B6, folate, and methionine with the risk of esophageal cancer: the Japan Public Health Center-based (JPHC) prospective study. BMC Cancer 21:1.
Crossref
Qiao-Li Wang & Jesper Lagergren. (2021) Response to Lai. American Journal of Gastroenterology 116:8, pages 1758-1758.
Crossref
I-Chen Wu, Yao-Kuang Wang, Yi-Hsun Chen, Chun-Chieh Wu, Meng-Chieh Wu, Wei-Chung Chen, Wen-Lun Wang, Hung-Shun Lin, Chou-Cheng Chen, Shah-Hwa Chou, Yu-Peng Liu & Ming-Tsang Wu. (2021) High Serum Elafin Prediction of Poor Prognosis of Locoregional Esophageal Squamous Cell Carcinoma. Cancers 13:12, pages 3082.
Crossref
Aaron P. Thrift. (2021) Global burden and epidemiology of Barrett oesophagus and oesophageal cancer. Nature Reviews Gastroenterology & Hepatology 18:6, pages 432-443.
Crossref
Georg E. Luebeck, Thomas L. Vaughan, Kit Curtius & William D. Hazelton. (2021) Modeling historic incidence trends implies early field cancerization in esophageal squamous cell carcinoma. PLOS Computational Biology 17:5, pages e1008961.
Crossref
Deepika SavantQingzhao ZhangZhaohai Yang. (2021) Squamous Neoplasia in the Esophagus. Archives of Pathology & Laboratory Medicine 145:5, pages 554-561.
Crossref
Harriet Rumgay, Melina Arnold, Mathieu Laversanne, David C. Whiteman, Aaron P. Thrift, Wenqiang Wei, Valery E. P. P. Lemmens & Isabelle Soerjomataram. (2021) International Trends in Esophageal Squamous Cell Carcinoma and Adenocarcinoma Incidence. American Journal of Gastroenterology 116:5, pages 1072-1076.
Crossref
Chang Seok Bang, Jae Jun Lee & Gwang Ho Baik. (2021) Computer-aided diagnosis of esophageal cancer and neoplasms in endoscopic images: a systematic review and meta-analysis of diagnostic test accuracy. Gastrointestinal Endoscopy 93:5, pages 1006-1015.e13.
Crossref
Jiwei Cheng, Haibo Ma, Ming Yan & Wenqun Xing. (2021) THAP9-AS1/miR-133b/SOX4 positive feedback loop facilitates the progression of esophageal squamous cell carcinoma. Cell Death & Disease 12:4.
Crossref
Qiao-Li WangEivind Ness-JensenGiola SantoniShao-Hua XieJesper Lagergren. (2021) Development and Validation of a Risk Prediction Model for Esophageal Squamous Cell Carcinoma Using Cohort Studies. American Journal of Gastroenterology 116:4, pages 683-691.
Crossref
Mimi C. Tan, Sheena Bhushan, Timothy Quang, Richard Schwarz, Kalpesh H. Patel, Xinying Yu, Zhengqi Li, Guiqi Wang, Fan Zhang, Xueshan Wang, Hong Xu, Rebecca R. Richards-Kortum & Sharmila Anandasabapathy. (2021) Automated software-assisted diagnosis of esophageal squamous cell neoplasia using high-resolution microendoscopy. Gastrointestinal Endoscopy 93:4, pages 831-838.e2.
Crossref
M.G. Davey, C.M. Davey, É.J. Ryan, A.J. Lowery & M.J. Kerin. (2021) Combined breast conservation therapy versus mastectomy for BRCA mutation carriers – A systematic review and meta-analysis. The Breast 56, pages 26-34.
Crossref
Matthew Smale, Julia Freckelton & Jacinta A. Holmes. (2021) Hematemesis, Abnormal Liver Function, and Polymicrobial Bacteremia: A Rare Complication of a Common Cancer. Gastroenterology 160:4, pages 1031-1033.
Crossref
Akira Yokoyama, Tai Omori & Tetsuji Yokoyama. (2020) Risk factors for esophageal iodine‐unstained lesions and changing trends among Japanese alcohol‐dependent men (2003‐2018). Cancer Science 112:2, pages 734-743.
Crossref
Halie K. MillerRobyn A. StoddardSanford M. DawseyDariush NasrollahzadehChristian C. AbnetArash EtemadiFarin KamangarGwen MurphyMasoud SotoudehGilbert J. KershReza MalekzadehM. Constanza Camargo. (2021) Association Between Serological Responses to Two Zoonotic Ruminant Pathogens and Esophageal Squamous Cell Carcinoma. Vector-Borne and Zoonotic Diseases 21:2, pages 125-127.
Crossref
Junjie Huang, Anastasios Koulaouzidis, Wojciech Marlicz, Veeleah Lok, Cedric Chu, Chun Ho Ngai, Lin Zhang, Ping Chen, Shanjuan Wang, Jinqiu Yuan, Xiang-Qian Lao, Shelly L.A. Tse, Wanghong Xu, Zhi-Jie Zheng, Shao-Hua Xie & Martin C.S. Wong. (2021) Global Burden, Risk Factors, and Trends of Esophageal Cancer: An Analysis of Cancer Registries from 48 Countries. Cancers 13:1, pages 141.
Crossref
Vetri Sudar JayaprakasamRandy YehGeoffrey Y. KuIva PetkovskaJames L. FuquaIIIIIIMarc GollubViktoriya Paroder. (2020) Role of Imaging in Esophageal Cancer Management in 2020: Update for Radiologists. American Journal of Roentgenology 215:5, pages 1072-1084.
Crossref
Ian Yu Hong Wong, Ka On Lam, Wendy Chan, Claudia Wong, Tsz Him So, Kwan Kit Chan, Cheuk Wai Choi, Tsz Ting Law, Keith Chiu, Fion Siu Yin Chan, Dora Lai Wan Kwong & Simon Law. (2020) Real-world Scenario: CROSS Regimen as Preoperative Therapy for Oesophageal Squamous Cell Carcinoma. Journal of Gastrointestinal Surgery 24:9, pages 1937-1947.
Crossref
Tomohiro Matsuda, Young-Joo Won, RuRu Chun-ju Chiang, Jiwon Lim, Kumiko Saika, Keisuke Fukui, Wen-Chung Lee, Laura Botta, Alice Bernasconi & Annalisa Trama. (2020) Rare cancers are not rare in Asia as well: The rare cancer burden in East Asia. Cancer Epidemiology 67, pages 101702.
Crossref
Wendy A. Brown, Yazmin Johari Halim Shah, George Balalis, Ahmad Bashir, Almino Ramos, Lilian Kow, Miguel Herrera, Scott Shikora, Guilherme M. Campos, Jacques Himpens & Kelvin Higa. (2020) IFSO Position Statement on the Role of Esophago-Gastro-Duodenal Endoscopy Prior to and after Bariatric and Metabolic Surgery Procedures. Obesity Surgery 30:8, pages 3135-3153.
Crossref
Franciska J. Gudenkauf & Aaron P. Thrift. (2020) Preventable causes of cancer in Texas by race/ethnicity: Alcohol consumption. Alcohol 85, pages 21-26.
Crossref
Milan Vošmik, Miroslav Hodek, David Buka, Petra Sýkorová, Jakub Grepl, Petr Paluska, Simona Paulíková & Igor Sirák. (2020) Cardiotoxicity of radiation therapy in esophageal cancer. Reports of Practical Oncology & Radiotherapy 25:3, pages 318-322.
Crossref
Huiwu Li, Hui Li, Yibulayin Waresijiang, Yan Chen, Ying Li, Liang Yu, Yike Li & Ling Liu. (2020) Clinical significance of HDAC1, -2 and -3 expression levels in esophageal squamous cell carcinoma. Experimental and Therapeutic Medicine 20:1, pages 315-324.
Crossref
Mohamed M. Gad, Anas M. Saad, Muneer J. Al-Husseini, Youssef M. Abdel-Gawad, Obai M. Alsalhani, Razan Alhaddad, Bashar Mohamad, Mohannad Abou Saleh & Carlos Roberto Simons-Linares. (2020) Temporal trends of pancreatic ductal adenocarcinoma in young adults in the United States: A Population-Based Study. Clinics and Research in Hepatology and Gastroenterology 44:2, pages 204-210.
Crossref
Wu-Wei Lai, Chia-Ni Lin, Chao-Chun Chang & Jung-Der Wang. (2020) Lifetime risks, expected years of life lost, and cost-per-life year of esophageal cancer in Taiwan. Scientific Reports 10:1.
Crossref
Dhaval Choksi, KailashM Kolhe, Meghraj Ingle, Chetan Rathi, Harshad Khairnar, ShamshersinghG Chauhan, Vipul Chaudhary, Akash Shukla & Vikas Pandey. (2020) Esophageal carcinoma: An epidemiological analysis and study of the time trends over the last 20 years from a single center in India. Journal of Family Medicine and Primary Care 9:3, pages 1695.
Crossref
Qiao-Li WangGiola SantoniEivind Ness-JensenJesper LagergrenShao-Hua Xie. (2020) Association Between Metformin Use and Risk of Esophageal Squamous Cell Carcinoma in a Population-Based Cohort Study. American Journal of Gastroenterology 115:1, pages 73-78.
Crossref
Enhao Liang, Junwei Sun & Yanfeng Wang. 2020. Bio-inspired Computing: Theories and Applications. Bio-inspired Computing: Theories and Applications 467 481 .
Alfred K. Lam. 2020. Esophageal Squamous Cell Carcinoma. Esophageal Squamous Cell Carcinoma 1 6 .
Akira Yokoyama, Tai Omori & Tetsuji Yokoyama. (2019) Changing trends in cancer incidence of upper aerodigestive tract and stomach in Japanese alcohol‐dependent men (1993‐2018). Cancer Medicine 9:2, pages 837-846.
Crossref
Pengjun Zhou, Ziyao Li, Dandan Xu, Ying Wang, Qi Bai, Yue Feng, Guifeng Su, Pengxiao Chen, Yao Wang, Huizhong Liu, Xiaogang Wang, Rong Zhang & Yifei Wang. (2019) Cepharanthine Hydrochloride Improves Cisplatin Chemotherapy and Enhances Immunity by Regulating Intestinal Microbes in Mice. Frontiers in Cellular and Infection Microbiology 9.
Crossref
Allon Kahn, Michael D. Crowell & David E. Fleischer. (2019) Reducing the risk of esophageal squamous cell carcinoma: out with the old; in with the new. Gastrointestinal Endoscopy 89:4, pages 733-735.
Crossref
Qiao-Li Wang, Jesper Lagergren & Shao-Hua Xie. (2019) Prediction of individuals at high absolute risk of esophageal squamous cell carcinoma. Gastrointestinal Endoscopy 89:4, pages 726-732.e2.
Crossref
Ian Wong & Simon Law. (2018) The management of mid & proximal oesophageal squamous cell carcinoma. Best Practice & Research Clinical Gastroenterology 36-37, pages 85-90.
Crossref
Shao-Hua Xie & Jesper Lagergren. (2018) Risk factors for oesophageal cancer. Best Practice & Research Clinical Gastroenterology 36-37, pages 3-8.
Crossref